Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
Option Care Health Inc (OPCH) delivers essential home and alternate-site infusion services across all 50 states, serving patients with complex medical needs through clinical expertise and innovative care models. This dedicated news hub provides investors and healthcare professionals with timely updates on the company's strategic initiatives, financial performance, and industry leadership.
Access authoritative information about OPCH's operational milestones, including merger integrations, service expansions, and clinical protocol enhancements. Our curated collection features earnings announcements, partnership developments, and regulatory updates that shape the home infusion care landscape.
Key content categories include quarterly financial disclosures, leadership changes, treatment innovation announcements, and market position analyses. This resource enables stakeholders to monitor OPCH's progress in improving patient outcomes while maintaining cost-effective care delivery systems.
Bookmark this page for continuous access to verified OPCH developments. Combine regular monitoring with professional financial analysis when evaluating the company's role in evolving healthcare markets.
Option Care Health (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, has scheduled its first quarter 2025 financial results announcement for Tuesday, April 29, 2025, before market opening. The company will host a conference call at 8:30 a.m. E.T. on the same day to discuss the results.
Investors can pre-register for the conference call through a provided link, and an audio webcast will be available at investors.optioncarehealth.com. A replay of the call will be accessible via webcast for approximately 90 days after the event.
Option Care Health (NASDAQ: OPCH) has released its Q4 and full-year 2024 financial results, showing strong revenue growth but mixed profitability metrics. Q4 2024 highlights include net revenue of $1,346.4M (up 19.7% YoY), net income of $60.1M, and adjusted EBITDA of $121.6M (up 8.9% YoY).
Full-year 2024 performance showed net revenue of $4,998.2M (up 16.2% YoY), though net income decreased to $211.8M from $267.1M in 2023. The company's gross profit margin declined to 20.3% from 22.8% in 2023.
For 2025 guidance, Option Care Health projects net revenue of $5.3B-$5.5B, adjusted EBITDA of $450M-$470M, and adjusted EPS of $1.59-$1.69. The company repurchased approximately $90.0M of stock in Q4 2024.
Option Care Health (NASDAQ: OPCH) released preliminary Q4 and full-year 2024 results, along with 2025 guidance. For Q4 2024, the company expects net revenue of $1.34-1.35B (19.2-20.1% growth), net income of $56.8-60.9M, and adjusted EBITDA of $118.7-121.7M.
Full-year 2024 projections include net revenue of $4.99-5.00B (16.0-16.2% growth), net income of $208.5-212.6M, and cash flow from operations exceeding $300M. For 2025, OPCH forecasts net revenue of $5.2-5.4B and adjusted EBITDA of $445-465M, noting a $60-70M negative gross profit impact from Stelara pricing adjustments.
The company also announced a new $500 million stock repurchase program after completing its previous $90M buyback in Q4 2024. The program has no expiration date and allows for various repurchase methods including open market purchases and block trades.
Option Care Health (OPCH), the largest independent provider of home and alternate site infusion services in the United States, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The event will take place in San Francisco, with Option Care Health scheduled to present on Monday, January 13, 2025, at 1:30pm PT.
The company, which employs over 7,500 team members including more than 4,500 clinicians, operates across all 50 states, providing care for patients with acute and chronic conditions. Interested parties can access the webcast and presentation materials through the company's investor relations website at investors.optioncarehealth.com.
Option Care Health (OPCH), the largest independent provider of home and alternate site infusion services in the US, announces participation in three upcoming investor conferences in November and December 2024. The company will attend the Jefferies London Healthcare Conference on November 19 with a fireside chat at 8:30am GMT, the Bank of America Leveraged Finance Conference in Boca Raton on December 3 with a presentation at 8:50am ET, and the virtual Bank of America Home Care Conference on December 9 with a fireside chat at 11:10am ET.
Webcasts and presentation materials will be accessible at investors.optioncarehealth.com. The company operates nationwide with over 7,500 team members, including 4,500+ clinicians, serving patients with acute and chronic conditions.
Option Care Health (OPCH) reported Q3 2024 financial results with net revenue of $1,278.5 million, up 17.0% year-over-year. However, gross profit margin decreased to 20.1% from 23.3% in Q3 2023. Net income declined 4.3% to $53.9 million. The company faced supply chain disruptions due to Hurricane Helene affecting IV solution bags availability. Updated 2024 guidance projects net revenue of $4.9-4.95 billion and Adjusted EBITDA of $438-443 million. Cash flow from operations significantly improved to $160.4 million compared to $61.0 million in Q3 2023.
Option Care Health Inc. (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the US, has announced it will release its third quarter 2024 financial results on Wednesday, October 30, 2024, before the market opens. The company will host a conference call at 8:30 a.m. E.T. on the same day to review the results.
Participants can pre-register for the conference call using the provided link. Additionally, a live audio webcast will be available on the company's investor relations website. A replay of the call will be accessible via webcast for on-demand listening shortly after the call's completion and will remain available for approximately 90 days.
Option Care Health (Nasdaq: OPCH) reported its Q2 2024 financial results, showing mixed performance. Net revenue increased 14.8% to $1,227.2 million, but gross profit decreased 0.6% to $249.4 million. Net income fell 53.6% to $53.0 million, or $0.30 per diluted share. Adjusted EBITDA slightly decreased by 1.5% to $108.4 million.
The company updated its full-year 2024 guidance, expecting net revenue between $4.75 billion and $4.85 billion, and Adjusted EBITDA of $435 million to $450 million. Option Care Health maintains its projection for cash flow from operations of at least $300 million.
Notable actions include repurchasing approximately $78.1 million of stock and amending the First Lien Credit Agreement to reduce interest rates and increase liquidity by $50.0 million.
Option Care Health (NASDAQ: OPCH), a leading provider of home and alternate site infusion services, will announce its second quarter 2024 financial results on July 31, 2024, before the market opens. The company will also hold a conference call at 8:30 a.m. E.T. on the same day to discuss the results.
Participants can pre-register for the call through a designated link, and a live audio webcast will be available online. A replay of the call will be accessible for 90 days after the event.
Option Care Health, the largest independent national provider of home and alternate site infusion services, announced its participation in three upcoming investor conferences. These include the William Blair 44th Annual Growth Stock Conference in Chicago on June 4, 2024, the Jefferies Global Healthcare Conference in New York on June 5, 2024, and the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 11, 2024. Presentations and fireside chats will be held at each event, and webcast links along with related materials will be available on the company's investor relations website.
